BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20944681)

  • 21. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.
    Wang CY; Wang S
    Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo.
    Park F; Kay MA
    Mol Ther; 2001 Sep; 4(3):164-73. PubMed ID: 11545606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic cytokine-inducible gene expression from retroviral vectors.
    Saylors RL; Stine KC; Derrick J
    Gene Ther; 1999 May; 6(5):944-6. PubMed ID: 10505121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
    Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
    Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
    Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
    Higashimoto T; Urbinati F; Perumbeti A; Jiang G; Zarzuela A; Chang LJ; Kohn DB; Malik P
    Gene Ther; 2007 Sep; 14(17):1298-304. PubMed ID: 17597793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer.
    Alfa RW; Blesch A
    Methods Mol Med; 2006; 129():241-54. PubMed ID: 17085815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
    Beutelspacher SC; Ardjomand N; Tan PH; Patton GS; Larkin DF; George AJ; McClure MO
    Exp Eye Res; 2005 Jun; 80(6):787-94. PubMed ID: 15939034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancer-deleted retroviral vectors restore high levels of superoxide generation in a mouse model of CGD.
    Schwickerath O; Brouns G; Thrasher A; Kinnon C; Roes J; Casimir C
    J Gene Med; 2004 Jun; 6(6):603-15. PubMed ID: 15170731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WPRE-mediated enhancement of gene expression is promoter and cell line specific.
    Klein R; Ruttkowski B; Knapp E; Salmons B; Günzburg WH; Hohenadl C
    Gene; 2006 May; 372():153-61. PubMed ID: 16488559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-inactivating lentiviral vectors with U3 and U5 modifications.
    Iwakuma T; Cui Y; Chang LJ
    Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
    Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M
    J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. General principles of retrovirus vector design.
    Chang T; Yee JK
    Methods Enzymol; 2012; 507():1-14. PubMed ID: 22365766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.
    Schambach A; Galla M; Maetzig T; Loew R; Baum C
    Mol Ther; 2007 Jun; 15(6):1167-73. PubMed ID: 17406345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroviral vectors encoding a reverse transcription-activated transgene efficiently limit expression of the gene to target cells.
    Burke JD; Morris JC
    Mol Ther; 2007 Mar; 15(3):552-9. PubMed ID: 17191073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.
    Modlich U; Bohne J; Schmidt M; von Kalle C; Knöss S; Schambach A; Baum C
    Blood; 2006 Oct; 108(8):2545-53. PubMed ID: 16825499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
    Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
    Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses.
    Hendrie PC; Huo Y; Stolitenko RB; Russell DW
    Mol Ther; 2008 Mar; 16(3):534-40. PubMed ID: 18209733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of a two-long-terminal-repeat junction molecule in the cytoplasm of recombinant murine leukemia virus-infected cells.
    Serhan F; Penaud M; Petit C; Leste-Lasserre T; Trajcevski S; Klatzmann D; Duisit G; Sonigo P; Moullier P
    J Virol; 2004 Jun; 78(12):6190-9. PubMed ID: 15163712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.